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Abstract We recently showed that Helicobacter pylori grown
on plates produce cecropin-like antibacterial peptides to which
H. pylori is resistant. This antibacterial activity was traced to
fragments from the N-terminus of ribosomal protein L1 (Pu«tsep
et al., Nature, April 22, 1999). The evolutionary suggestion from
this finding has now been extended by the synthesis of eight
peptides with sequences taken from the N-terminus of ribosomal
protein L1 (RpL1) of five different species. Two peptides of
different length derived from H. pylori RpL1 showed a potent
antibacterial activity, while a peptide with the sequence from
Escherichia coli was 20 times less active. Like cecropins the H.
pylori peptides were not cytolytic. We suggest that the cecropins
have evolved from ribosomal protein L1 of an ancestral
intracellular pathogen that developed to a symbiont ending as
an organelle. When the R1 gene moved into the host nucleus, a
duplication provided a copy from which today cecropins could
have evolved.
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1. Introduction
Gene-encoded antibacterial peptides constitute the central
e¡ector molecules of innate immunity and based on their 3D
structures they have been grouped into three or ¢ve distinct
classes [1,2]. One group have six cysteines, the K- and L-de-
fensins forming £at L-sheets [3]. Defensins are widely distrib-
uted among animals and insects. Plants have similar mole-
cules, but so far no such peptides are known from
microorganisms. An other group of peptides are free of cys-
teines and they often form amphipathic K-helices such as the
cecropins. The 3D structure of cecropin A was determined [4].
Numerous peptides have been designed, many of them based
on cecropin sequences, in part with the aim of obtaining po-
tential drug candidates [5^7].
Gene-encoded antibacterial peptides are made by animals
and plants as well as by some bacteria. A group called lanthi-
biotics are posttranslationally undergoing several chemically
interesting modi¢cations [8]. However, a number of linear
peptides with antibacterial activity such as lactococcin A are
also known. Surprisingly, we recently found that Helicobacter
pylori grown in vitro contains a signi¢cant antibacterial activ-
ity that could be traced to several cecropin-like peptides de-
rived from the N-terminal part of ribosomal protein L1 [9].
Since this ¢nding would provide a lead to the evolution of the
cecropins, we report here the activity of several synthetic pep-
tides corresponding to the N-terminal sequences of ribosomal
proteins from ¢ve di¡erent species. Of those made so far, the
Helicobacter peptides are most potent.
2. Materials and methods
2.1. Synthetic peptides and sequences for ribosomal L1 proteins
The peptides derived from the N-terminus of ¢ve di¡erent riboso-
mal proteins L1 were purchased from Neosystem (Strasbourg,
France). The purity of the peptides was checked by the manufacturer
using HPLC. All sequences for the ribosomal proteins L1 were ob-
tained from GenBank. The length of peptides Hp(2^13), Hp(2^20),
Hp(2^38), Hp(20^38), Ec(2^19), Tt(2^19), Pp(2^18) and Syn(2^20) are
indicated by solid lines under the respective sequences in Fig. 1. Ce-
cropins A and P1 as well as melittin were kindly synthesized some
time ago by David Andreu and David Wade.
2.2. Bacterial strains and antibacterial assays
Escherichia coli K12 strain W3110 expresses a wild-type lipid A in
contrast to its msbB mutant which is defective in the ¢nal acylation
step of the lipid A part of its lipopolysaccharide (LPS), [10]. E. coli
D21 and Bacillus megaterium strain Bm11 are streptomycin resistant
mutants frequently used as assay organisms [11].
Antibacterial activity was determined using the inhibition zone
method [11]. Indicator bacteria were suspended in 6 ml of LB agarose
and casted in a 9 cm Petri dish. Small holes (diameter 3 mm) were
punched in the thin bacteria agarose layer. For each peptide, a 2-fold
dilution series of the peptide was applied to the holes and the plates
were incubated overnight at 28‡C. The diameters of the growth in-
hibition zones were used to calculate the lethal concentration (LC in
WM) which is the lowest concentration of peptide that will inhibit
bacterial growth. The LC values were calculated using the formula
given in [11]. Small zones deviate from the linear relation and in these
cases the LC values were calculated directly from the diameter using
the alternative formula [11].
In the killing rate experiment, 10 Wl aliquots were withdrawn at
indicated time points, diluted to 100 Wl and spread on LB plates for
viable count determination. The concentration of the Hp(2^20) pep-
tide was 3.5 WM.
3. Results
Fig. 1 shows the N-terminal sequences for ribosomal pro-
tein L1 from ¢ve di¡erent species and the sequence for cecro-
pins A and B from Hyalophora cecropia. Residues 3^11 in the
cecropins and in H. pylori L1 constitute a highly conserved
box with six identical residues and three highly conserved
residues (Fig. 1). The 3D structure of cecropin A shows that
the molecule has two helices (residues 4^21 and 25^37) con-
nected by a hinge composed of residues AGP [4]. The Heli-
cobacter sequence can be plotted into two helices (residues 1^
18 and 22^38). Fig. 2 shows that the ¢rst helix from H. pylori
L1 and from cecropin can both be plotted as perfect or almost
perfect amphipathic Edmundson wheels. In the wheel for the
E. coli protein the A2 residue is interrupting the hydrophilic
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side of the wheel, an e¡ect that could be corrected by a ¢rst
base substitution.
An important characteristic found when the ¢rst cecropins
were isolated [12] was that they did not lyse chromium la-
belled animal cells, while the bee venom peptide melittin
was highly lytic. Fig. 3 shows that neither the Hp(2^20) nor
cecropin P1 lysed the intestinal cell line AGS while melittin
gave 80% lysis. A prolonged incubation for 18 h gave the
same result (data not shown).
We have synthesized eight N-terminal peptides (see Fig. 1),
four with sequences derived from H. pylori L1 and four from
four other species and tested them for antibacterial activity
against B. megaterium and E. coli K12. One of the H. pylori
peptides was devoid of activity, namely Hp(22^38) and this
was the case also for the peptides derived from the N-terminal
parts of the L1 proteins of P. porpurea chloroplast, T. ther-
mophilus and Synechocystis strain PCC 6803. The antibacte-
rial activities found against our common assay organisms E.
coli D21 and B. megaterium Bm11 are given in Table 1.
Clearly the most active peptide was Hp(2^38) containing
both helices and thus conceptually being most similar to the
cecropins. However, both of the shorter H. pylori peptides
were active. The E. coli peptide showed a low but clearly
detectable activity against B. megaterium. The presence of
Medium E [13] gave a 20-fold increase in potency for the
long H. pylori peptide, most likely an e¡ect due to increased
helix formation as previously documented for FALL-39 [14].
It should be stressed that all peptides were found to be
inactive on H. pylori. Table 1 shows that in general the
Gram-positive B. megaterium was more susceptible to the
RpL1 derived peptides than was E. coli. However, the E.
coli LPS mutant msbB (with only ¢ve fatty acid residues in-
stead of normally six) was clearly more sensitive to the H.
pylori peptides than was the wild-type. Interestingly, none of
the cecropins detected this LPS di¡erence.
As pointed out before an e¡ector of innate immunity
should be able to eliminate an invading organism in a time
shorter than the doubling time of the bacterium [2]. We have
therefore performed a rate experiment using the peptide
Hp(2^20) and the bacterium B. megaterium. Fig. 4 shows
that viable count dropped to zero after 8 min incubation at
37‡C with a peptide concentration closed to the LC value.
Fig. 1. Sequences for the N-terminal part of ribosomal protein L1 from ¢ve di¡erent species, H. pylori (Hp), E. coli (Ec), T. termophilus (Tt),
P. porpurea chloroplast (Pp) and Synechocystis PCC 6803 (Syn). The length of the peptides synthesized are indicated by solid lines below the
respective sequences. For comparison the top part shows the sequences for cecropins B and A from H. cecropia. The boxed in sequences show
the most similar part of the H. pylori and the cecropin sequences.
Fig. 2. Edmundson wheel diagram of cecropin A, H. pylori ribosomal protein L1 and E. coli ribosomal protein L1. The residue numbers are
given in the center under the names. The H. pylori wheel is a perfect amphipathic K-helix with the upper part hydrophobic and the lower part
hydrophilic.
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4. Discussion
Five years ago a global eradication of H. pylori was dis-
cussed [15]. The ¢nding of cecropin-like peptides in extracts of
H. pylori together with the known fact that the bacterium can
undergo ‘altruistic lysis’ [16] opens the possibility that the
organism is of importance for the natural balance of the hu-
man micro£ora [9]. Thus, it not clear that a universal erad-
ication of H. pylori should be undertaken before more knowl-
edge is accumulated about the dynamics of the normal human
micro£ora.
The Hp RpL1 peptides and two cecropins were inactive
against the strains of H. pylori tested (A5, MO19, P466, and
CCUG17874) [9]. It has been suggested that cecropin A binds
to the diphosphoryl lipid A moiety of LPS [17]. The lower
amounts of phosphates in H. pylori lipid A [18] could be one
way by which this organism is cecropin resistant. The msbB
mutant, lacking one fatty acid residue in its LPS, was more
sensitive to Hp(2^20) than was the wild-type (Table 1). This
di¡erence was not detected by the cecropins. Like the cecro-
pins, the Helicobacter peptide HP(2^20) showed no lytic or
toxic activity against the intestinal cell line AGS (Fig. 3).
It has been suggested that the ¢rst gene-encoded peptide
antibiotics did evolve from a competitive need of slow-grow-
ing eukaryotic organisms to counteract fast-growing organ-
isms in the same ecosystem [1]. Since bacterial cell surfaces
in general, like DNA and RNA, are negatively charged, DNA
and RNA binding proteins are obvious candidates for the
origin of antibacterial peptides. The ¢sh antibacterial peptide
parasin I was shown to be processed from histone H2A [19].
Thus, in itself it could be expected that ribosomal proteins are
candidates for the evolution of antibacterial peptides. For E.
coli RpL1, RNAse protection assays and genetic evidence
show that the charged N-terminus is involved in RNA binding
[20]. Also the E. coli RpL1 peptide Ec(2^19) had activity, but
only against a Gram-positive bacteria and it was around ¢ve
times less active than the H. pylori peptide Hp(2^20) (Table
1). The fact that the longer Helicobacter peptide Hp(2^38) has
two potential helical regions and a much higher activity than
Hp(2^20) does emphasize the similarity with the moth cecro-
pins.
The L1 peptides derived from the thermophilic bacterium
T. thermophilus Tht(2^19), the alga Synechocystis PCC 6803
Syn(2^20) and plant P. porpurea chloroplast Pp(2^18) were all
devoid of activity (data not shown). Thus, these ¢ndings do
not provide any evidence about the evolution of the cecropins
from the L1 proteins of these three organisms. However, the
sequences derived from two Gram-negative bacteria (H. pylori
and E. coli) suggest that the cecropins could have evolved
from an early RpL1 gene in a particular prokaryote. This
ancestral bacterium may have been H. pylori like and changed
from being an intracellular parasite of an ancient eukaryotic
organism to become a symbiont and ¢nally ending up as an
organelle of the host. Since many organelle host genes today
are located in the nucleus, one can suggest that a duplicated
copy of the L1 gene served as the original genetic material
from which today cecropins have evolved.
Fig. 3. Release of 51chromium from the human intestinal cell line
AGS after 2 h incubation at 37‡C with decreasing amount of di¡er-
ent peptides. Filled columns Hp(2^20), highest conc. 23 WM; striped
columns cecropin P1 and dotted columns melittin, for both highest
conc. 3 WM.
Table 1
Antibacterial activity of four L1 derived peptides and two cecropins
Strain peptide D21 W3110 msbB Bm11 Bm11+MedE
Hp(2^13) 200 s 570 30 5 8
Hp(2^20) 20 35 8 5 3
Hp(2^38) 5 5 3 8 0.4
Ec(2^19) s 260 s 260 s 260 20 19
Cecropin A 0.4 0.2 0.1 0.6 0.7
Cecropin P1 0.2 0.1 0.2 4 3
Activities are given as lethal concentrations (LC values in WM) [11]. Strains D21 and W3110 are derivatives of E. coli K12 and the latter is the
parental strain for the msbB mutant. Bm11 is a streptomycin resistant mutant of B. megaterium. Other details are given in Section 2. Medium
E (MedE) is used because it can promote helix formation [14].
Fig. 4. Rate of killing of B. megaterium by the synthetic peptide
Hp(2^20) at 37‡C. The solvent was LB medium and the control was
without any addition. The last sample taken at 8 min was sterile.
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